Skip to main content
Advancing Precision Oncology Through Artificial Intelligence
Waqas Haque, MD, MPH
Expert Analysis
By Waqas Haque, MD, MPH In this latest edition of The Way Ahead: The Convergence of Technology and Cancer Care, Dr. Waqas Haque shares his perspectives on machine learning models for classifying cancer immunophenotypes in lung cancer; Insilico Medicine's artificial intelligence–driven process behind the development of INS018_055, a promising drug for idiopathic pulmonary fibrosis; the approval of lisocabtagene maraleucel for chronic lymphocytic leukemia/small lymphocytic lymphoma; and more! 
Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability With Joseph Kalis, PharmD, BCOP; Matthew Hadfield, DO; Samuel Kareff, MD, MPH
Keira Smith
Expert Analysis
This April, Oncology Data Advisor is raising awareness for Esophageal Cancer Awareness Month. In this interview, Oncology Data Advisor Editorial Board and Fellows Forum members Dr. Joseph Kalis, Dr. Matthew Hadfield, and Dr. Samuel Kareff discuss rising trends, treatment advances, and emerging management strategies for esophageal cancer, including ...
Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on the LINKER-MM1 Trial From AACR 2024 With Alankrita Taneja, MD, and Sundar Jagannath, MD
Keira Smith
Expert Analysis
In this interview from the American Association for Cancer Research (AACR) 2024 Annual Meeting, Dr. Alankrita Taneja, third-year Hematology/Oncology Fellow at Roswell Park Cancer Institute and Oncology Data Fellows Forum Member, speaks with Dr. Sundar Jagannath, Professor of Medicine (Hematology and Medical Oncology) and Director of the Center of E...
Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass With Jason Mouabbi, MD; Valerie Brutus, MD, FACS; and Elizabeth Stirling Craig, MD
Lyn Brook
Expert Analysis
In this interview, Jason Mouabbi, MD, an Oncology Data Advisor Editorial Board Member and Assistant Professor in the Department of Breast Oncology at the University of Texas MD Anderson Cancer Center, sat down with Valerie Brutus, MD, FACS, a Breast Surgical Oncologist at St. Vincent's Medical Center of Hartford HealthCare, and Elizabeth Stirling C...
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research and Clinical Trials With Christopher Lieu, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous research advances occurring in this field during the past year, Dr. Lieu sat down with us again to share updates in targeted therapies for HER2-positive metastatic colorectal cancer and the evolving landscape of biomarkers under investigation for this disease.Click the links below for Hitting the Target in HER2-Positive Metastatic Colorectal Cancer, an accredited CME/NCPD activity provided by i3 Health! 
Celebrating National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
Lyn Brook
Expert Analysis
Oncology Data Advisor® · National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO In this edition of the Oncology Data Fellows Forum in celebration of National Doctor's Day, Samuel Kareff, MD, MPH, and Matthew Hadfield, DO, discuss the highs and lows of working in this field and why it is important to take a mome...
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes With Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan
Keira Smith
Expert Analysis
Oncology Data Advisor® · Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant therapy, considerations for genetic testing, and the importance of clinical trial participation for bringing these new advances to the forefront of care. 
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research and Clinical Trials With Christopher Lieu, MD
Keira Smith
Expert Analysis
Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous research advances occurring in this field during the past year, Dr. Lieu sat down with us again to share updates in targeted therapies for HER2-positive metastatic colorectal cancer and the evolving landscape of biomarkers under investigation for this disease.Click the links below for Hitting the Target in HER2-Positive Metastatic Colorectal Cancer, an accredited CME/NCPD activity provided by i3 Health!
Fighting Hereditary Colorectal Cancer Through Genetic Counseling With Catherine Skefos, MA, MS, CGC, and Julie Moskowitz, MS
Keira Smith
Expert Analysis
Oncology Data Advisor® · Fighting Hereditary Colorectal Cancer With Genetic Counseling: Catherine Skefos and Julie Moskowitz In this edition of "Bridging the Gap in Cancer Care Through Genetic Counseling," Editorial Member Catherine Skefos speaks with her colleague Julie Moskowitz, MS, Genetic Counselor in the Gastrointestinal (GI) Center at MD Anderson Cancer Center, about hereditary aspects of colorectal cancer, how she counsels patients and families regarding their risk of colorectal cancer and related syndromes, and how genetic testing can be used to inform screening decisions and ultimately reduce patients' risk.  
International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship From Richa Thakur, Nida Khan, Lauren Ghazal, and Gurbakhash Kaur
Keira Smith
Expert Analysis
Oncology Data Advisor® · International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship In this panel discussion in honor of International Women's Day on March 8, Dr. Richa Thakur, Dr. Nida Khan, Dr. Lauren Ghazal, and Dr. Gurbakhash Kaur discuss their perspectives as women in the fields of medicine and nursing, including their advice for negotiating, seeking mentors, overcoming imposter syndrome, building confidence, and making your voice heard.  
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). In this interview, Dr. Cataland provides an update on new research that has occurred in the field during the past year and shares a preview of what learners can look forward to when attending his presentation at their own institution.  
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Donika Saporito, MS
Keira Smith
Expert Analysis
Oncology Data Advisor® · Kidney Cancer Awareness Month: Spotlight on Genetic Counseling In this interview for Kidney Cancer Awareness Month, Hiam Abdel-Salam, MS, CGC, speaks with Donika Saporito, MS, a Certified Genetic Counselor in the Genitourinary Center at MD Anderson Cancer Center, who provides an overview of genetic testing for hereditary kidney cancer syndromes and how she personally counsels the patients she sees.  
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
Lyn Brook
Expert Analysis
Oncology Data Advisor® · Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education (CME)–/nursing continuing professional development ...
AYA Cancer Awareness Week: Creating Welcoming Spaces for Support and Advocacy With Dr. Lauren Ghazal, Megan-Claire Chase, and Allison Rosen
Keira Smith
Expert Analysis
Oncology Data Advisor® · AYA Cancer Awareness Week 2024 Adolescent and Young Adult (AYA) Cancer Awareness Week, April 1 to 5, 2024, is a time to shine a spotlight on adolescent and young adult cancer patients and survivors. To commemorate the week, Lauren Ghazal, Megan-Claire Chase, and Allison Rosen, all members of the Oncology Data Advisor Editorial Board, sat down for a conversation to highlight the issues that AYA cancer patients face, including fertility preservation and financial toxicity; the need to ensure that race, ethnicity, and sexual orientation are not overlooked when building welcoming support spaces for all patients; and the value of turning to the AYA community for support while also serving as your own best advocate.  
AYA Cancer Awareness Week: Creating Welcoming Spaces for Support and Advocacy With Dr. Lauren Ghazal, Megan-Claire Chase, and Allison Rosen
Keira Smith
Expert Analysis
Adolescent and Young Adult (AYA) Cancer Awareness Week, April 1 to 5, 2024, is a time to shine a spotlight on adolescent and young adult cancer patients and survivors. To commemorate the week, Lauren Ghazal, Megan-Claire Chase, and Allison Rosen, all members of the Oncology Data Advisor Editorial Board, sat down for a conversation to highlight the issues that AYA cancer patients face, including fertility preservation and financial toxicity; the need to ensure that race, ethnicity, and sexual orientation are not overlooked when building welcoming support spaces for all patients; and the value of turning to the AYA community for support while also serving as your own best advocate.  
Fighting Hereditary Colorectal Cancer Through Genetic Counseling With Catherine Skefos, MA, MS, CGC, and Julie Moskowitz, MS
Keira Smith
Expert Analysis
In this edition of "Bridging the Gap in Cancer Care Through Genetic Counseling," Editorial Member Catherine Skefos speaks with her colleague Julie Moskowitz, MS, Genetic Counselor in the Gastrointestinal (GI) Center at MD Anderson Cancer Center, about hereditary aspects of colorectal cancer, how she counsels patients and families regarding their risk of colorectal cancer and related syndromes, and how genetic testing can be used to inform screening decisions and ultimately reduce patients' risk.  
Multiple Myeloma Awareness Month 2024: What Patients Need to Know
Keira Smith
Expert Analysis
Oncology Data Advisor® · Multiple Myeloma Awareness Month 2024: What Patients Need to Know For Multiple Myeloma Awareness Month this March, Oncology Data Advisor hosted a live panel discussion geared towards patients living with multiple myeloma. Dr. Rahul Banerjee, Dr. Alankrita Taneja, Dr. Richa Thakur, and Dr. Gurbakhash Kaur helped p...
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
Lyn Brook
Expert Analysis
Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education (CME)–/nursing continuing professional development (NCPD)–approved virtual tumor board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma, alongs...
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kelly Rone, DNP, RN, AGNP-c, Advanced Practice Nurse at the Mayo Clinic. With numerous developments in the field occurring since recording the activity, Dr. Ajani sat down with Oncology Data Advisor to provide an update on the evolving field of esophagogastric cancer research and advances to look forward to in the coming years.  
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
Keira Smith
Expert Analysis
Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). In this interview, Dr. Cataland provides an update on new research that has occurred in the field during the past year and shares a preview of what learners can look forward to when attending his presentation at their own institution.